Received Mar 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Wrong storage/that since it was received in the facility, Priorix had been faulty storaged at freezing temperatures; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received MMR (Priorix) for prophylaxis. Co-suspect products included priorix pre-filled syringe device injection syringe for prophylaxis. On an unknown date, the patient received Priorix and priorix pre-filled syringe device. On an unknown date, an unknown time after receiving Priorix and priorix pre-filled syringe device, the patient experienced incorrect storage of drug (Verbatim: Wrong storage/that since it was received in the facility, Priorix had been faulty storaged at freezing temperatures). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-FEB-2026 Patient had been received in the facility, Priorix had been stored improperly at freezing temperatures. According to the reporter, the lowest recorded temperature had been -3°F. The batch number was not provided, and we are unable to contact the reporter.